SCHEMBL2012204

SCHEMBL2012204

CN(C(=O)c1n[nH]c2c1CCC2)C(CCNC(=O)c1cccn1C)Cc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.58
HCRTR2 O43614 2/20 0.58
NPC1 O15118 5/20 0.45
RAB9A P51151 5/20 0.45
RIPK1 Q13546 3/20 0.39
PARP1 P09874 1/20 0.39
CBLB Q13191 2/20 0.37
PKM P14618 1/20 0.37
MAPT P10636 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
LMNA P02545 2/20 0.37
HTT P42858 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
PLA2G1B P04054 1/20 0.36
ATG4B Q9Y4P1 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
PADI4 Q9UM07 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2015396 0.86 HCRTR1 (0.57) HCRTR1HCRTR2NPC1RAB9APARP1
SCHEMBL6918605 0.86 HCRTR1 (0.57) HCRTR1HCRTR2NPC1RAB9APARP1
SCHEMBL2013812 0.83 HCRTR1 (0.59) HCRTR1HCRTR2NPC1RAB9ASMN1; SMN2
SCHEMBL2054137 0.80 HCRTR1 (0.56) HCRTR1HCRTR2NPC1RAB9APARP1
SCHEMBL2013158 0.80 HCRTR1 (0.56) HCRTR1HCRTR2NPC1RAB9APARP1
SCHEMBL13139060 0.80 HCRTR1 (0.77) HCRTR1HCRTR2NPC1RAB9AKMT2A
SCHEMBL2015628 0.80 HCRTR1 (0.57) HCRTR1HCRTR2NPC1RAB9ASMN1; SMN2
SCHEMBL2012839 0.78 HCRTR1 (0.59) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2012866 0.78 HCRTR1 (0.59) HCRTR1HCRTR2NPC1RAB9AMAPT
SCHEMBL2012867 0.78 HCRTR1 (0.59) HCRTR1HCRTR2NPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO claimed
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed